Genetic Technologies Limi... (GENE)
NASDAQ: GENE
· Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM
Genetic Income Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 4.8M | 3.96M | 4.53M | 4.15M | 4.74M | 2.88M | 2.05M | 1.73M | 104.12K | 659.15K | 16.44K |
Cost of Revenue | 2M | 5.94M | 5.76M | 5.7M | 1.82M | 942.33K | 1.31M | 564.44K | 472.91K | 6.28K | 286.66K |
Gross Profit | 2.8M | -1.98M | -1.22M | -1.55M | 2.93M | 1.94M | 741.19K | 1.16M | -368.8K | 652.87K | -270.22K |
Operating Income | -3.47M | -5.16M | -4.58M | -5.39M | -4.31M | -1.83M | -4.97M | -1.95M | -4.18M | -1.87M | -4.45M |
Interest Income | 29.64K | 89.87K | 140.41K | 79.75K | 36.26K | 5.12K | 10.8K | 5.4K | 53.48K | 26.74K | 7.42K |
Pretax Income | -5.6M | -6.42M | -6.3M | -5.61M | -4.47M | -1.64M | -5.09M | -1.94M | -4.06M | -1.8M | -4.02M |
Net Income | -5.6M | -6.42M | -6.29M | -5.46M | -3.25M | -1.62M | -3.88M | -1.94M | -3.6M | -1.8M | -3.48M |
Selling & General & Admin | 5.9M | 3.71M | 3.65M | 4.11M | 8.66M | 2.85M | 3.58M | 2.3M | 1.77M | 1.29M | 3.11M |
Research & Development | 363K | 389.76K | 722.85K | 558.31K | -1.43M | 167.27K | 2.13M | 185.48K | 2.05M | 51.92K | 1.06M |
Other Expenses | n/a | 914.35K | 1.01M | 823.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.27M | 3.18M | 3.36M | 3.85M | 7.24M | 3.59M | 5.71M | 3.11M | 3.81M | 2.49M | 4.17M |
Interest Expense | 38.77K | 12.85K | 13.64K | 15.87K | n/a | n/a | 15.99K | n/a | 6.63K | n/a | 7.42K |
Selling & Marketing Expenses | 1.57M | 1.25M | 1.3M | 1.65M | 1.14M | 570.2K | 901.63K | 450.82K | 162.31K | 81.16K | 598.59K |
Cost & Expenses | 8.27M | 9.12M | 9.11M | 9.55M | 9.06M | -2.64M | 7.02M | -2.54M | 4.29M | -2.49M | 4.46M |
Income Tax Expense | n/a | -5 | -10.32K | -148.01K | -1.22M | 16.06K | -1.21M | n/a | -457.91K | n/a | -540K |
Shares Outstanding (Basic) | 4.97M | 134.07K | 107.26K | 107.26K | 102.5K | 10.25M | 102.2K | 10.22M | 99.06K | 9.89M | 90.83K |
Shares Outstanding (Diluted) | 4.97M | 134.07K | 107.26K | 107.26K | 102.5K | 10.25M | 102.2K | 10.22M | 99.06K | 9.89M | 90.83K |
EPS (Basic) | -1.13 | -4.78 | -5.86 | -5.09 | -3.17 | -0.02 | -3.8 | -0.02 | -3.64 | -0.02 | -3.82 |
EPS (Diluted) | -1.13 | -4.78 | -5.86 | -5.09 | -3.17 | -0.02 | -3.8 | -0.02 | -3.64 | -0.02 | -3.82 |
EBITDA | -5.47M | -6.13M | -5.94M | -5.06M | -4.1M | -1.79M | -4.86M | -1.81M | -3.72M | -1.78M | -3.87M |
EBIT | -5.43M | -5.16M | -5.02M | -5.39M | -4.47M | -1.83M | -5.08M | n/a | -4.05M | n/a | -4.01M |
Depreciation & Amortization | -43.56K | 280.67K | 346.4K | 330.19K | 364.09K | 25.11K | 214.58K | 165.09K | 337.11K | 31.06K | 141.11K |